tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market

Barinthus Biotherapeutics (BRNS) Technical Analysis

Compare
108 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Barinthus Biotherapeutics’s (BRNS) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Barinthus Biotherapeutics is a Buy.
Barinthus Biotherapeutics’s (BRNS) 20-Day exponential moving average is 0.60, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) 50-Day exponential moving average is 0.65, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.

Barinthus Biotherapeutics (BRNS) Pivot Points

Mar 29, 2026, 01:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.55
0.55
0.55
0.55
0.55
0.55
0.55
Fibonacci
0.55
0.55
0.55
0.55
0.55
0.55
0.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Barinthus Biotherapeutics (BRNS) Moving Averages

Mar 29, 2026, 01:35 PM
Period
Simple
Exponential
MA5
0.56Sell
0.57Sell
MA10
0.61Sell
0.58Sell
MA20
0.60Sell
0.60Sell
MA50
0.65Sell
0.65Sell
MA100
0.71Sell
0.74Sell
MA200
0.97Sell
0.88Sell
Barinthus Biotherapeutics’s (BRNS) 10-Day exponential moving average is 0.58, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) 100-Day exponential moving average is 0.74, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 50-day simple moving average is 0.65, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 100-day simple moving average is 0.71, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 200-day simple moving average is 0.97, creating a Sell signal.

Barinthus Biotherapeutics (BRNS) Technical Indicators

Mar 29, 2026, 01:35 PM
Name
Value
Implied Action
RSI (14)
37.55
Neutral
STOCH (9,6)
22.62
Neutral
STOCHRSI (14)
22.62
Neutral
MACD (12,26)
-0.02
Buy
ADX (14)
23.82
Neutral
Williams %R
-77.38
Buy
CCI (14)
-110.52
Buy
ATR (14)
0.05
-
Ultimate Oscillator
28.42
Sell
ROC
-1.79
Sell
Barinthus Biotherapeutics’s (BRNS) Relative Strength Index (RSI) is 37.55, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Trend Strength Indicator (ADX) is 23.82, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Commodity Channel Index (CCI) is -110.52, creating a Buy signal.
Barinthus Biotherapeutics’s (BRNS) Price Rate of Change (ROC) is -1.79, creating a Sell signal.

FAQ

Is BRNS a Buy, Hold, or Sell?
Based on BRNS’s technical indicators, BRNS is a Strong Sell.
    What is BRNS’s RSI (14)?
    BRNS’s RSI (14) is 37.55, which suggests BRNS is a Neutral.
      What is BRNS’s MACD?
      BRNS’s MACD is -0.02, which suggests BRNS is a Buy.
        What is BRNS’s 5-day moving average?
        BRNS’s 5-day moving average is 0.56, which suggests BRNS is a Sell.
          What is BRNS’s 20-day moving average?
          BRNS 20-day moving average is 0.60, which suggests BRNS is a Sell.
            What is BRNS’s 50-day moving average?
            BRNS’s 50-day moving average is 0.65, which suggests BRNS is a Sell.
              What is BRNS’s 200-day moving average?
              BRNS’s 200-day moving average is 0.97, which suggests BRNS is a Sell.
                What is BRNS’s Williams % R (14)?
                BRNS’s Williams % R (14) is -77.38, which suggests BRNS is a Buy.
                  What is BRNS’s CCI (14)?
                  BRNS’s CCI (14) is -110.52, which suggests BRNS is a Buy.